IVF clinic insurance market seen reaching $6.68 billion by 2030

The IVF clinic insurance market is projected to rise from $4.47 billion in 2025 to $6.68 billion by 2030 as fertility treatment use grows, cyber risks mount and clinics seek broader liability protection. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - IVF clinic insurance is becoming more important as fertility treatment demand grows and clinics face higher exposure to malpractice, equipment, cyber and operational risks. - The market’s growth reflects broader pressure on healthcare providers to protect patient data, maintain continuity and manage increasingly complex IVF operations. - More demand for specialized coverage can make fertility services easier to sustain and potentially more accessible.

What happened: - The Business Research Company said the IVF clinic insurance market reached $4.47 billion in 2025 and is projected to rise to $4.86 billion in 2026. - The market is forecast to reach $6.68 billion by 2030. - The report projects an 8.7% CAGR from 2025 to 2026 and an 8.3% CAGR through 2030. - The research is part of The Business Research Company’s In Vitro Fertilization (IVF) Clinic Insurance Global Market Report 2026.

The details: - IVF clinic insurance is designed to cover financial risks tied to medical procedures, patient lawsuits, equipment malfunctions and operational liabilities in assisted reproductive technology. - Growth has been driven by a rising number of IVF clinics, more medical malpractice claims, greater awareness of risk management, broader assisted reproductive technology services and tighter healthcare liability rules. - Future demand is expected to be supported by cyber liability insurance, digital health platform adoption, investment in fertility healthcare infrastructure, specialized insurance products and more complex IVF laboratory operations. - Key market trends include tailored fertility-clinic policies, cyber coverage for patient information, integrated risk-management and compliance advisory services, business interruption insurance for IVF labs and broader liability packages. - The report says rising infertility is a major growth driver. - Infertility is defined as the inability to conceive after 12 months of regular, unprotected intercourse or difficulty carrying a pregnancy to term. - Delayed childbearing is contributing to infertility as fertility declines with age through reduced egg quality, ovarian reserve and sperm health. - The World Health Organization reported in April 2023 that about 17.5% of adults worldwide, or about 1 in 6 people, experience infertility. - Rising IVF use is also expanding demand for insurance. - The American Society for Reproductive Medicine said in April 2026 that more than 100,000 infants were born through IVF in the U.S. in a single year. - North America held the largest market share in 2025. - Asia-Pacific is expected to grow the fastest during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market outlook suggests fertility care is becoming more industrialized, with insurers building products around a specialized clinical and digital risk profile. - Cyber coverage stands out because IVF clinics handle sensitive patient information and increasingly depend on digital systems. - The regional split suggests the market is already mature in North America, while newer demand may be building in Asia-Pacific.

What's next: - The market is likely to keep expanding as more clinics adopt digital tools, handle more procedures and seek broader protection. - Specialized policies and bundled risk-management services may become more common as insurers compete for fertility-clinic business. - The report points to continued global growth across both established and emerging IVF markets.

The bottom line: - IVF clinic insurance is moving from niche coverage to a growing healthcare risk-management category, with rising fertility treatment demand and cyber exposure pushing the market toward $6.68 billion by 2030.